The fact that NEP enzyme activity contributes to both IR pathophysiology (8, 9) and PCOS pathophysiology (7) suggests that NEP inhibitors may have a potential role in the strategies to be developed for PCOS treatment. The gene discussed is MME; the disease is polycystic ovary syndrome.